Fundz

Mirum Pharmaceuticals Appoints Dr. Rob Myers as Chief Medical Officer

PUBLIC · MIRMSep 08, 2026

Position

Chief Medical Officer

Company

Mirum Pharmaceuticals, Inc.

Rob Myers
Foster CityHealthcarePharmaceutical Manufacturing

Description

Mirum Pharmaceuticals has announced the appointment of Dr. Rob Myers as their new Chief Medical Officer. This strategic hire is expected to strengthen the company’s leadership in developing therapies for liver diseases.

Quick answer

Mirum Pharmaceuticals Appoints Dr. Rob Myers as Chief Medical Officer (September 8, 2026). Mirum Pharmaceuticals, Inc. is based in Foster City, California, United States.

Who is the new Chief Medical Officer at Mirum Pharmaceuticals, Inc?
Mirum Pharmaceuticals, Inc. named Rob Myers Chief Medical Officer, announced September 8, 2026.
What did Mirum Pharmaceuticals, Inc. announce on September 8, 2026?
Mirum Pharmaceuticals has announced the appointment of Dr. Rob Myers as their new Chief Medical Officer. This strategic hire is expected to strengthen the company’s leadership in developing therapies for liver diseases.
What does Mirum Pharmaceuticals, Inc. do?
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults.
Where is Mirum Pharmaceuticals, Inc. based?
Mirum Pharmaceuticals, Inc. is based in Foster City, California, United States.

Source: Fundz verified event record.

Who to call at Mirum Pharmaceuticals, Inc., and when

A new leader at Mirum Pharmaceuticals, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Mirum Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mirum Pharmaceuticals, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mirum Pharmaceuticals, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mirum Pharmaceuticals, Inc.

Location

989 East Hillsdale Boulevard, Suite 300

Foster City, California, United States

About

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI® (maralixibat) oral solution, Cholbam® (cholic acid) capsules, and Chenodal® (chenodiol) tablets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mirum Pharmaceuticals, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Eric
Likely contact at this company
••••••••@••••••••

See Eric's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Mirum Pharmaceuticals, Inc.'s next move

Learn about Strategic plan

Mirum Pharmaceuticals, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.